2016
DOI: 10.1016/j.jnutbio.2016.02.010
|View full text |Cite
|
Sign up to set email alerts
|

Protective role of n6/n3 PUFA supplementation with varying DHA/EPA ratios against atherosclerosis in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
30
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 45 publications
(34 citation statements)
references
References 53 publications
3
30
1
Order By: Relevance
“…Nonetheless, a stronger effect was not observed in the best performance group among DHA/EPA groups as compared with the DHA group in mice with high-fat diet-induced obesity. Accordingly, the ability of DHA/EPA with an n-6/n-3 ratio of 4:1 to modulate the alteration in lipid oxidation and hepatic oxidative damage was substantial; this result is in line with an existing report showing that supplementation with PUFAs induced changes in the oxidation state [16]. …”
Section: Discussionsupporting
confidence: 88%
See 4 more Smart Citations
“…Nonetheless, a stronger effect was not observed in the best performance group among DHA/EPA groups as compared with the DHA group in mice with high-fat diet-induced obesity. Accordingly, the ability of DHA/EPA with an n-6/n-3 ratio of 4:1 to modulate the alteration in lipid oxidation and hepatic oxidative damage was substantial; this result is in line with an existing report showing that supplementation with PUFAs induced changes in the oxidation state [16]. …”
Section: Discussionsupporting
confidence: 88%
“…Nevertheless, the best performance groups treated with DHA/EPA did not show better results than those in the DHA group. These findings seemed to contradict our previous report that indicated that serum TC and LDL-C levels were the lowest in the 2:1 DHA/EPA group, because the highest serum HDL-C content was observed in the 1:1 DHA/EPA group in apoE −/− mice [16]. These findings may be explained by the lack of apoE, a ligand for receptors that clear remnants of chylomicrons and very low density lipoproteins, and accumulation of apoE is expected to cause accumulation in plasma of cholesterol-rich residues [22].…”
Section: Discussioncontrasting
confidence: 85%
See 3 more Smart Citations